Got to News overview Newsroom

UNITE4TB Expert Interview Series Complete

News News

We are delighted to announce the conclusion of the UNITE4TB Expert Interview Series, featuring 11 thought-provoking conversations with leading voices from across the consortium.

Over the course of the series, we’ve explored topics including:

  • The journey and vision of UNITE4TB
  • Challenges and successes encountered along the way
  • Insights into clinical trials, diagnostics, and drug development
  • The vital role of community engagement, public–private collaboration, and scientific innovation
  • Reflections on sustainability and lessons that can be carried forward

Watch the complete playlist here

Or start with our original teaser video shown above for a preview of what’s inside.

Highlights from the Series
 

  • Derek Sloan, UNITE4TB Project Coordinator, set the stage with the project’s journey and goals
  • Michael Hoelscher, UNITE4TB Scientific Lead, tackled drug pipeline challenges and innovation
  • Jodie Schildkraut, UNITE4TB WP5 Co-Lead, provided an overview of ongoing trials and cross-trial learnings
  • Dominic Wakerley, PARADIGM4TB Clinical Research Fellow, shared PARADIGM4TB insights at a pivotal moment
  • Christoph Lange, UNITE4TB Clinical Lead, discussed the urgency for new regimens
  • Christian Lienhardt, UNITE4TB WP2 member, positioned UNITE4TB in the wider R&D ecosystem
  • Bouke de Jong, UNITE4TB Scientific Advisory Board member, reflected on scientific positioning and impact
  • Blessina Kumar, UNITE4TB Community Advisory Group member, emphasized community engagement and policy translation
  • Daniela Cirillo, UNITE4TB WP6 Co-Lead, focused on diagnostics, harmonization, and implementation
  • Maria Beumont, UNITE4TB WP4 member, explained asset ownership and the value of TB Alliance’s participation in the project
  • David Barros-Aguirre, UNITE4TB Project Lead, closed the series with reflections on progress, transferable lessons, public-private synergy, and sustainability

This video series is more than content — it’s a repository of collective expertise, experience, and vision. We hope it will serve as a resource and inspiration for researchers, advocates, funders, policymakers, and all those committed to accelerating new TB treatment regimens. Thank you to all interviewees for their participation and to everyone who followed along. 

Subscribe to our YouTube channel and follow us on LinkedIn for updates from UNITE4TB.

Share this page…